Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2020-07-10 2020-07-10
Drug Identification Number 00021261 00021261
Brand name TEVA-CHLOROQUINE TEVA-CHLOROQUINE
Common or Proper name CHLOROQUINE 250MG TABLETS CHLOROQUINE 250MG TABLETS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CHLOROQUINE DIPHOSPHATE CHLOROQUINE DIPHOSPHATE
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code P01BA P01BA
ATC description ANTIMALARIALS ANTIMALARIALS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2019-11-21 2019-11-21
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Need to source and validate an alternate API Supplier Need to source and validate an alternate API Supplier
Health Canada comments